Canada’s Aurora Cannabis Inc. is seeking to takeover CanniMed Therapeutics in an all-stock $455 million deal, according to a Bloomberg report. The deal values CanniMed stock at C$24 a share, 57 percent above Tuesday’s Toronto Stock Exchange closing price. Aurora Executive Vice President Cam Battley told Bloomberg that the firm is “making a very big push into Europe” and the …
